Frontlight ResearchEarly access
Kidney cancer trials in United States
210 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bethesda, Bethlehem, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, Effingham, El Paso, Falls Church, Fargo, Flint, Fort Lauderdale, Fort Myers, Fort Sam Houston, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Loxahatchee Groves, Lubbock, Macon, Madera, Madison, Marshfield, Mattoon, Maywood, McAllen, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Niles, Norfolk, Normal, Norton Shores, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Reed City, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Santa Barbara, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Torrance, Traverse City, Tucson, Tulsa, Urbana, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winfield, Winston-Salem, Worcester, Wyoming, Yorkville
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - Phase 2Taking peopleA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Birmingham, Boise, Boston, Buffalo, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Macon, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Milwaukee, Minneapolis, Mobile, Morristown, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Worcester
- Age
- Up to 30 years
- People
- 256 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04322318 - Phase 1/2Taking peopleTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Boston, Chicago, Cincinnati, Houston, Indianapolis, Los Angeles, Memphis, Minneapolis, New York, Orange, Palo Alto, Philadelphia, Pittsburgh, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 12 months to 30 years
- People
- 147
- Run by
- Children's Oncology Group
See details and how to joinNCT04851119 - Phase 1/2Taking peopleYttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
- Where
- Aurora, Los Angeles
- Age
- 18 years and over
- People
- 25
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT06432036 - No phaseTaking peopleStereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 30
- Run by
- NYU Langone Health
See details and how to joinNCT07767500 - Phase 1/2Taking peoplePersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Where
- Jacksonville
- Age
- 16 years and over
- People
- 138
- Run by
- Mayo Clinic
See details and how to joinNCT05269381 - Phase 2Taking peoplePhase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06940518 - Phase 2Taking peopleA Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
- Where
- Boston
- Age
- 18 years and over
- People
- 25
- Run by
- Stephanie Berg
See details and how to joinNCT07123090 - Phase 2Taking peopleGenetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
- Where
- Cleveland, Dallas, Duarte, Nashville, Orange
- Age
- 18 years and over
- People
- 54
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT05361720 - Phase 1Taking peopleStudy of DCC-2812 in Participants With Advanced Genitourinary Cancers
- Where
- Ann Arbor, Austin, Boston, Cleveland, Nashville, Philadelphia, San Antonio, St Louis
- Age
- 18 years and over
- People
- 60
- Run by
- Deciphera Pharmaceuticals, LLC
See details and how to joinNCT06966024 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Clovis, Hackensack, Houston, Iowa City, Los Angeles, Nashville, Newport Beach, New York, Portland
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Active, not recruitingA Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- Where
- Atlanta, Boston, Buffalo, Hackensack, Nashville, New Orleans, New York, Orlando, San Antonio
- Age
- 18 years and over
- People
- 738 worldwide
- Run by
- NextCure, Inc.
See details and how to joinNCT06792552 - Early phase 1Taking peopleNeoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT05733715 - Phase 1Taking peopleSelective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
- Where
- Washington D.C.
- Age
- 1 year to 23 years
- People
- 18
- Run by
- Children's National Research Institute
See details and how to joinNCT07172958 - Phase 1Taking peopleModulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
- Where
- Houston
- Age
- 18 years and over
- People
- 16
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07187869 - Phase 1Taking peopleA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Boston, Nashville, New York, Philadelphia, San Antonio
- Age
- 18 years and over
- People
- 281 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07195682 · EU 2025-522543-18-00 - Phase 1Taking peopleInterleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Where
- Houston
- Age
- 1 year to 21 years
- People
- 24
- Run by
- Baylor College of Medicine
See details and how to joinNCT04715191 - No phaseNot yet taking people in United StatesTransplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
- Where
- Cleveland
- Age
- 60 years and over
- People
- 5
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT05725421 - Phase 1Not yet taking people in United StatesMercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 18
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT07716735 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Houston, San Antonio, St Louis
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - No phaseTaking peoplePET/MR for Characterization of Renal Masses (RMs)
- Where
- Dallas, Houston
- Age
- 18 years and over
- People
- 97
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06076538 - Phase 1Taking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Atlanta, Charlotte, Chicago, Cincinnati, Columbus, Duarte, Durham, Jacksonville, Louisville, Nashville, New Brunswick, New Haven, New York, Oklahoma City, Phoenix, Rochester, Sacramento, Seattle
- Age
- 18 years and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - Phase 1/2Taking peopleInulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 55
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT06866262 - Phase 1Taking peopleSitagliptin With Pembro in RCC and Melanoma
- Where
- Iowa City
- Age
- 18 years to 99 years
- People
- 64
- Run by
- Fernando Maciel Barbosa
See details and how to joinNCT07634380 - Phase 1Taking peopleA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Where
- Allentown, Dallas, Germantown, Hackensack
- Age
- 18 years and over
- People
- 437 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06764771